Diseases, Conditions, Syndromes

EU plans vaccines as regulator sets approval deadline

European countries were on Tuesday given a clear timeframe for the start of their vaccination programmes after the bloc's medicines regulator said it would decide by December 29 whether to grant emergency approval for the ...

Diseases, Conditions, Syndromes

Pfizer seeks EU vaccine approval as OECD sees recovery in 2021

Pharma companies Pfizer and BioNTech on Tuesday filed for European approval for their coronavirus vaccine, following in the footsteps of competitor Moderna, while the OECD predicted the world economy would bounce back to ...

Diseases, Conditions, Syndromes

France to ease lockdown as world ramps up vaccine preparations

France on Tuesday was set to become the latest country to ease coronavirus restrictions in the run-up to Christmas, as Russia joined in a flurry of encouraging announcements about possible vaccines.

Diseases, Conditions, Syndromes

World ramps up COVID-19 vaccine preparations

Hopes over COVID-19 vaccines have given a boost to virus-weary citizens across the globe in recent days, but the disease remains rampant and world leaders are urging people to be patient.

Vaccination

Vaccine roll out nears as US closes early for holidays

US giant Pfizer and its German partner BioNTech prepared Friday to file an emergency request to roll out their vaunted vaccine while New York shut its schools and California braced for nighttime curfews heading into the US ...

Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

page 18 from 28